Inventor · disambiguated record
Mark Czekaj
Also filed as: CZEKAJ MARK
10 granted patents·4 pending applications·128 citations·filing 1989–2024
87Inventor score
Files withAVENTIS PHARMA INC4GENZYME CORP3RHONE POULENC RORER PHARMA3CHOI-SLEDESKI YONG MI2RORER PHARMACEUTICAL CORP1
Top patents by PatentIndex Score
14 records- 0186US4952562AAnti-thrombotic peptides and pseudopeptidesRORER PHARMACEUTICAL CORP·Filed 1989·Granted Aug 28, 1990·57 cites·12 claims
- 0284US11274108B2Colony stimulating factor-1 receptor (CSF-1R) inhibitorsGENZYME CORP·Filed 2016·Granted Mar 15, 2022·2 cites·15 claims
- 0384US6977263B2Chemical compoundsAVENTIS PHARMA INC·Filed 2001·Granted Dec 20, 2005·27 cites·59 claims
- 0479US12503477B2Colony stimulating factor-1 receptor (CSF-1R) inhibitorsGENZYME CORP·Filed 2024·Granted Dec 23, 2025·0 cites·6 claims
- 0569US2022396588A1Colony stimulating factor-1 receptor (csf-1r) inhibitorsGENZYME CORP·Filed 2022·Application pending·0 cites
- 0664US5332726AAntithrombotic peptides and pseudopeptidesRHONE POULENC RORER PHARMA·Filed 1992·Granted Jul 26, 1994·22 cites·21 claims
- 0755US8183231B2Substituted propane phosphinic acid derivativesCHOI-SLEDESKI YONG MI·Filed 2006·Granted May 22, 2012·0 cites·34 claims
- 0852US5780590AAntithrombotic azacycloalkylalkanoyl peptides and pseudopeptidesRHONE POULENC RORER PHARMA·Filed 1996·Granted Jul 14, 1998·7 cites·5 claims
- 0949US5051405AAnti-thrombotic peptides and pseudopeptidesRHONE POULENC RORER PHARMA·Filed 1989·Granted Sep 24, 1991·13 cites·7 claims
- 1048US8828974B2Substituted propane phosphinic acid derivativesCHOI-SLEDESKI YONG MI·Filed 2012·Granted Sep 9, 2014·0 cites·20 claims
- 1144US2007142435A1[4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptaseAVENTIS PHARMA INC·Filed 2006·Application pending·0 cites
- 1243US7361663B2N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor XaAVENTIS PHARMA INC·Filed 2003·Granted Apr 22, 2008·0 cites·20 claims
- 1339US2003092698A1N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor XaFiled 2002·Application pending·0 cites
- 1439US2005228018A1Chemical compoundsAVENTIS PHARMA INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →